Riskpilot← Back to searchSign inGet full accessKLINIKK OSLO AS
ASActiveOrg 994667777Hegdehaugsveien 31, 0352 OsloOther human health activities n.e.c. · NACE 8699Est. 20097 employees
Revenue 2024
NOK 2,2M
-44% vs 2023
EBITDA margin
-6.4%
+77% vs 2023
Equity ratio
-217.1%
Financial strength
Net profit 2024
NOK -186K
+73% vs 2023
| Revenue | NOK 2,2M | -44% |
| EBITDA | NOK -140K | +77% |
| Net profit | NOK -186K | +73% |
| Total assets | NOK 224K | -80% |
| Equity | NOK -486K | -62% |
| Employees | 7 | — |
Legal name
KLINIKK OSLO AS
Org number
994667777
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
21. oktober 2009
Share capital
NOK 1 000 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Styrets leder alene.
Company purpose
Tilby medisinske tjenester og andre helsetjenester, herunder også drive forskning og utvikling av nye medisinske tjenester i samarbeid med andre virksomheter, sykehus og offentlige forskningsinstitusjoner, og deltakelse i andre selskaper som hermed står i forbindelse.
Address
Hegdehaugsveien 31, 0352 Oslo
Phone
+4722980538
Email
firmapost@klinikkoslo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 048 | 7 604 | 6 455 | 3 889 | 2 178 |
| Staff expenses | −2 783 | −2 104 | −2 082 | −1 823 | −1 173 |
| EBITDA | 416 | 233 | −711 | −604 | −140 |
| Depreciation & amort. | −69 | −64 | −30 | −77 | −24 |
| EBIT | 348 | 170 | −741 | −681 | −164 |
| Net financials | −27 | −29 | −18 | −21 | −22 |
| Profit before tax | 320 | 141 | −759 | −702 | −186 |
| Tax | 70 | 49 | −0 | −0 | −0 |
| Net profit | 250 | 92 | −759 | −702 | −186 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 760 | 2 226 | 1 917 | 1 122 | 224 |
| Equity | 293 | 262 | 103 | −299 | −486 |
| Long-term debt | 363 | 323 | 734 | 743 | 488 |
| Short-term debt | 1 103 | 1 641 | 1 080 | 678 | 221 |
| Total debt | 1 467 | 1 965 | 1 814 | 1 421 | 709 |
EBITDA margin
-6.4%
This company
15.8%
Market median
-141% vs market
20202024
Equity ratio
-217.1%
This company
38.2%
Market median
-668% vs market
20202024
Return on equity
-18623800.0%
This company
18.4%
Market median
-101216404% vs market
20202024
Net profit margin
-8.6%
This company
8.1%
Market median
-206% vs market
20202024
Asset turnover
9.73×
This company
1.12×
Market median
+769% vs market
20202024
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Deputy Member | Deputy Member | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 14.29% | 14.29% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biozym Medical As
KLINIKK OSLO AS Board members of KLINIKK OSLO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marit Espeland Tholfsen | Deputy Member | 0 companies |
| Olav Espeland | Chairman | 0 companies |